Reportable Segments (Tables)

6 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

Schedule of Net Revenues, Operating Expenses Contribution Information by Reportable Segment

Segment net revenues, segment operating expenses and segment contribution information for the Company’s Actavis Pharma, Actavis Specialty Brands and Anda Distribution segments consisted of the following (in millions):

	Three Months Ended June 30, 2013												Three Months Ended June 30, 2012
	Actavis Pharma			Actavis Specialty Brands			Anda Distribution			Total			Actavis Pharma			Actavis Specialty Brands			Anda Distribution			Total
Product sales	$	1,525.5		$	126.9		$	275.8		$	1,928.2		$	976.0		$	100.9		$	240.9		$	1,317.8
Other		43.7			17.9			—			61.6			19.0			18.4			—			37.4
Net revenues		1,569.2			144.8			275.8			1,989.8			995.0			119.3			240.9			1,355.2
Operating expenses:
Cost of sales (1)		776.8			34.4			238.8			1,050.0			517.4			28.7			207.9			754.0
Research and development		103.7			31.9			—			135.6			53.8			25.9			—			79.7
Selling and marketing		160.9			47.0			27.7			235.6			52.6			42.5			22.8			117.9
Contribution	$	527.8		$	31.5		$	9.3		$	568.6		$	371.2		$	22.2		$	10.2		$	403.6
Contibution margin		33.6	%		21.8	%		3.4	%		28.6	%		37.3	%		18.6	%		4.2	%		29.8	%
General and administrative											225.8												121.8
Amortization											149.6												105.8
Loss on asset sales, impairments, and contingent consideration adjustment, net											655.3												79.8
Operating income (loss)										$	(462.1	)										$	96.2
Operating margin											(23.2	%)											7.1	%

(1) Excludes amortization of acquired intangibles, including product rights.

	Six Months Ended June 30, 2013												Six Months Ended June 30, 2012
	Actavis Pharma			Actavis Specialty Brands			Anda Distribution			Total			Actavis Pharma			Actavis Specialty Brands			Anda Distribution			Total
Product sales	$	3,049.6		$	243.1		$	506.8		$	3,799.5		$	2,084.0		$	193.8		$	539.5		$	2,817.3
Other		53.4			32.4			—			85.8			27.1			35.1			—			62.2
Net revenues		3,103.0			275.5			506.8			3,885.3			2,111.1			228.9			539.5			2,879.5
Operating expenses:
Cost of sales (1)		1,638.7			64.2			433.3			2,136.2			1,131.6			54.5			472.2			1,658.3
Research and development		202.5			65.2			—			267.7			109.9			58.3			—			168.2
Selling and marketing		320.2			90.6			52.0			462.8			100.1			90.2			45.7			236.0
Contribution	$	941.6		$	55.5		$	21.5		$	1,018.6		$	769.5		$	25.9		$	21.6		$	817.0
Contibution margin		30.3	%		20.1	%		4.2	%		26.2	%		36.5	%		11.3	%		4.0	%		28.4	%
General and administrative											411.6												286.2
Amortization											308.0												237.7
Loss on asset sales, impairments, and contingent consideration adjustment, net											803.3												80.0
Operating income (loss)										$	(504.3	)										$	213.1
Operating margin											(13.0	)%											7.4	%

(1) Excludes amortization of acquired intangibles, including product rights.